{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:35:52Z","timestamp":1770467752917,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jns.2024.122903","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T11:49:34Z","timestamp":1706010574000},"page":"122903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluating yield and utilization of ganglioside antibody testing in clinical practice"],"prefix":"10.1016","volume":"457","author":[{"given":"Cathy Meng Fei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiu-Chia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Budhram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jns.2024.122903_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jns.2024.122903_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JND-150078","article-title":"Diagnostic utility of auto antibodies in inflammatory nerve disorders","volume":"2","author":"Emilien","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"issue":"2","key":"10.1016\/j.jns.2024.122903_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-510X(99)00180-X","article-title":"Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile","volume":"168","author":"Yuki","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2024.122903_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2024.122903_bb0025","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in miller fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.jns.2024.122903_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.43.2.414","article-title":"Frequent presence of anti-GQ1b antibody in Fisher\u2019s syndrome","volume":"43","author":"Yuki","year":"1993","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.jns.2024.122903_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2024.122903_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","article-title":"Anti-GT1a IgG in Guillain-Barr\u00e9 syndrome","volume":"72","author":"Koga","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"5","key":"10.1016\/j.jns.2024.122903_bb0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.49.5.1289","article-title":"Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates","volume":"49","author":"Pestronk","year":"1997","journal-title":"Neurology."},{"issue":"22","key":"10.1016\/j.jns.2024.122903_bb0050","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181ff94c2","article-title":"Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology."},{"issue":"Pt 10","key":"10.1016\/j.jns.2024.122903_bb0055","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain."},{"issue":"5","key":"10.1016\/j.jns.2024.122903_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mus.24192","article-title":"Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism","volume":"49","author":"Yuki","year":"2014","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.jns.2024.122903_bb0065","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force\u2014second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2024.122903_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2024.122903_bb0075","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1515\/cclm-2018-0234","article-title":"Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme","volume":"56","author":"Franciotta","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.jns.2024.122903_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jns.12594","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"28","author":"van Doorn","year":"2023","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:07:00Z","timestamp":1758384420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":16,"alternative-id":["S0022510X24000388"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.122903","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating yield and utilization of ganglioside antibody testing in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.122903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122903"}}